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Zinc is an essential nutrient for all organisms because this metal serves as a catalytic or structural cofactor for many different proteins. Zinc-
dependent proteins are found in the cytoplasm and within many organelles of the eukaryotic cell including the nucleus, the endoplasmic reticulum,
Golgi, secretory vesicles, and mitochondria. Thus, cells require zinc transport mechanisms to allow cells to efficiently accumulate the metal ion
and distribute it within the cell. Our current knowledge of these transport systems in eukaryotes is the focus of this review.
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function of many proteins. Studies of the cell biology of zinc
date back perhaps to the discovery of the zinc-binding cytosolic
metallothionein (MT) protein by Margoshes and Vallee in 1957
[1]. For over 30 years thereafter, the study of MT by many labs
represented the frontier of the field. That changed dramatically
in the mid-1990s with the discovery of the first zinc transporters
responsible for the movement of zinc across cellular mem-
branes. Subsequent studies over the past 10 years have told us
much about these transporters and the molecular aspects of the
cell biology of zinc. In this review, I will examine many of these
new insights. I will first consider the level and forms of zinc
within cells and then go on to discuss the mechanisms by which
cells transport zinc across their plasma membranes and how
intracellular free zinc is distributed among the various
intracellular organelles.
1. The zinc quota, the zinc proteome, and intracellular free
zinc
How much zinc do cells require to thrive? The concept of the
“zinc quota” was first proposed by T. O'Halloran [2]. The zinc
quota is defined as the total zinc content of a cell required for its
optimum growth. In Escherichia coli, the zinc quota is⁎ Tel.: +1 608 263 1613; fax: +1 608 262 5860.
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doi:10.1016/j.bbamcr.2006.03.005approximately 105 atoms of zinc per cell [2]. The zinc quota
of yeast is estimated to be about 107 atoms per cell while many
mammalian cell types grown in culture require approximately
108 atoms per cell [3–5]. At face value, these numbers seem
quite different as they vary over three orders of magnitude.
However, when adjusted for the volume of these different types
of cells, there is remarkable similarity in the concentration of
zinc; each corresponds to a total cellular zinc concentration of
0.1–0.5 mM. These calculations treat cells bounded by their
plasma membranes as homogeneous “bags of buffer”; obvi-
ously, this is not true and zinc is distributed to varying degrees
among subcellular organelles as will be discussed below.
Nonetheless, these calculations do provide an approximation of
intracellular zinc concentrations.
There are certainly cell types that do not fit this rule. For
example, certain types of neurons and cells of the prostate
accumulate higher levels of zinc than other tissues, and this
reflects the specialized roles of zinc within these particular types
of cells [6,7]. For most types of cells, however, the
concentration of total zinc appears to be very similar. I propose
that this similarity likely reflects the conserved roles of zinc in
cellular biochemistry. These data also make two other important
points about the cell biology of zinc. First, while often referred
to as a “trace element”, zinc is obviously not a trace element
from the perspective of the cell [2]. Second, these data highlight
the ability of cells to accumulate and concentrate extracellular
metal ions. For example, E. coli and yeast can accumulate zinc
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[2,8].
In most cell types grown under normal conditions, the vast
majority of intracellular zinc is bound to proteins and serves in
essential structural or catalytic roles. I refer to this population of
zinc metalloproteins as the “zinc proteome”. While the zinc
proteome has not yet been considered in genome-wide detail,
there is sufficient information available from model organisms
such that we can get a sense of where this zinc is associated and
to what level. In yeast, for example, major zinc binding proteins
include Cu/Zn superoxide dismutase (SOD) and the predom-
inant isozyme of alcohol dehydrogenase (Adh1). Cu/Zn SOD
accumulates to about 5×105 molecules per cell while Adh1
accumulates to around 7.5×105 molecules per cell (accounting
for 1.5×106 atoms of zinc) [9,10]. Similarly, six atoms of zinc
are bound to each ribosome accounting for a total of 6×105
atoms of ribosomal zinc per cell [11]. These three examples
alone account for almost 20% of the total zinc quota of the yeast
cell. In addition to these high affinity sites, low affinity zinc
binding sites abound in the cell. These include weaker binding
sites on proteins, lipids, and DNA as well as small molecular
weight compounds such as organic anions (e.g., citrate), amino
acids (e.g., histidine), and glutathione.
Given these factors, it is likely that free zinc is present at very
low levels in cells. The term “free” here is used to specify labile
zinc that is freely available for binding by newly synthesized
zinc metalloproteins. Attempts to measure free zinc in cells have
produced a wide range of concentrations (10−5 to 10−12 M)
depending on the approach used [4,12–17]. One source of this
variability is that cytosolic extracts used for direct measure-
ments can be contaminated with organellar zinc and zinc
released from protein sites during the sample preparation due to
oxidation or proteolysis. In addition, studies using zinc-
responsive fluorophores are difficult to interpret because of
the problems associated with using high levels of fluorescent
probes to measure small pools of zinc [18]. Therefore, we still
have no clear idea of what intracellular free zinc levels really
are. Many zinc metalloproteins have metal binding affinities in
the nM to pM range, arguing that free zinc is also in that range
[19–22]. One nM corresponds to about 30 zinc atoms per yeast
cell and about 300 atoms in a mammalian cell. If these
predictions are correct, it is remarkable how low free zinc is
when total zinc is so high. For example, 1 nM free zinc
corresponds to less than 0.001% of the total zinc concentration
of the cell. This comparison highlights the precise control of
free zinc within cells and the delicate balance between zinc
transport (i.e., uptake, efflux, and organellar sequestration) and
the binding of zinc by newly synthesized metalloproteins.
A recent analysis of the affinity of zinc-responsive
transcription factors of E. coli has often been cited as evidence
for the absence of free zinc in cells. These factors, Zur and ZntR,
respond to zinc in the femtomolar (10−15 M) range which is
many orders of magnitude lower than the concentration of a
single atom of zinc in an E. coli cell [2]. This result suggested
that free Zn2+ is not utilized in cellular zinc transactions. Rather,
these authors suggested that zinc may be trafficking within the
cell bound to metallochaperones, as is the case for copper [23–25], that deliver zinc directly to metalloproteins via specific
protein–protein interactions. While formally possible, I believe
that this interpretation is unlikely for two reasons. First, it is
difficult to imagine a population of metallochaperone proteins
serving to deliver zinc to the hundreds of different zinc proteins
found within a cell. This would constitute a major investment of
an organism's genome and such an investment has not yet been
discovered. It is conceivable that a relatively few zinc
metallochaperones each deliver the metal to many different
zinc metalloproteins. If so, one would predict that common
mechanisms of protein–protein interaction would be conserved
among the target proteins of a particular metallochaperone. The
sequence conservation likely required to allow for these
protein–protein interactions has not been observed among
large groups of zinc proteins, e.g., zinc finger proteins. Thus,
while some zinc proteins may be of high priority and have
specific metallochaperones to maintain metallation under low
zinc conditions, it seems unlikely that metallochaperones are a
general mechanism of zinc trafficking.
In addition, the interpretation that there is no free zinc in cells
based on these data assumes that the cell is at equilibrium with
its environment. This is clearly not the case for living cells that
are subject to fluctuations in environmental conditions,
intracellular metabolism, and regulatory responses. Rather,
what seems more likely is that individual E. coli cells (and
probably other types of cells) rapidly cycle between periods of
intracellular zinc deficiency and zinc repletion. For example, a
zinc-deficient E. coli cell responds by increased expression of
zinc uptake transporters and decreased expression of zinc efflux
transporters. Zinc entering the cell would then shut off
expression of the uptake transporters and induce activity of
the efflux transporters. Because these responses are not
instantaneous, the cell would accumulate zinc in excess of its
demand level before the zinc-responsive changes in transporter
activity can occur. After uptake ceases, the accumulated excess
of zinc is then used by newly made zinc metalloproteins or is
effluxed from the cell. Once the bolus of intracellular zinc is
depleted, the cycle can begin anew. Thus, the high affinity of
transcription factors like ZntR and Zur for zinc would still allow
their function as “toggle switches” alternating between zinc
deficient and replete states. This scenario provides one simple
alternative explanation for how transcription factors with
femtomolar affinity can maintain zinc homeostasis.
2. Families of eukaryotic zinc transporters
The uptake of zinc into cells and its transport into and out of
intracellular organelles requires transporter proteins that span
these membranes to facilitate the movement of zinc. Zinc
transporters belong to at least 6 different transporter families.
Three of these, the ABC transporters, the RND transporters, and
the CorA proteins have been implicated in zinc transport in
bacteria but not in eukaryotes [26] and will not be considered
here. Similarly, few P-type ATPases have been found to play
roles in eukaryotic zinc transport. Known eukaryotic zinc
transporters come largely from two families, the ZIP (SLC39)
and CDF/ZnT (SLC30) proteins. These two families will be
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reviews for additional information [27–31].
2.1. The ZIP family of zinc transporters
The ZIP (Zrt-, Irt-like Protein) family is named after the yeast
Zrt1 protein and the Arabidopsis Irt1 protein. These were the
first identified members of this family. Mammalian members of
this family have been given the systematic designation
“SLC39” [30]. A key feature of the ZIP family is that, without
any yet known exceptions, these proteins transport zinc and/or
other metal ion substrates from the extracellular space or
organellar lumen into the cytoplasm.
ZIP transporters are found at all phylogenetic levels
including bacteria, fungi, plants, and mammals [32]. Most
ZIP proteins have eight predicted transmembrane domains and
similar predicted topologies with the N- and C-termini of the
protein located on the extracytoplasmic face of the membrane
(Fig. 1). Many members also have a long loop region located
between transmembrane domains 3 and 4, and a histidine-rich
sequence is frequently found in this TM3–4 loop. The function
of this domain is unclear, but its potential metal binding ability
suggests some function in zinc transport or its regulation.
However, mutations in these residues in the yeast Zrt1
transporter had no apparent effect on transporter function but
did alter the protein's subcellular localization [33]. The
mechanism of transport used by ZIPs is not clear. Zinc transport
by the yeast Zrt1 protein is energy dependent while the humanFig. 1. The predicted membrane topologies of the ZIP/SLC39 and CDF/Znt/
SLC30 families of metal ion transporters. The transmembrane domains are
numbered 1, 2, etc.Zip2 (SLC39A2) transporter is not [34,35]. Zinc uptake by this
mammalian transporter may be driven by the gradient of HCO3
−
that exists across the membrane of cells [35].
2.2. The CDF/Znt family of zinc transporters
The CDF designation stands for “cation diffusion facilitator”
[36]. Mammalian members have been named “ZnT” and given
the systematic name of SLC30 [31]. The key feature of this
family is that they transport zinc and/or other metal ions from
the cytoplasm into the lumen of intracellular organelles or to the
outside of the cell. Thus, CDF proteins work in opposition to the
ZIP transporters.
CDF transporters are also found at all phylogenetic levels
[32]. Most members of this family have six predicted
transmembrane domains (Fig. 1). Notable exceptions to this
rule are the Msc2 and Znt5 proteins that form heteromeric
complexes to transport zinc into compartments of the secretory
pathway. These two proteins have the canonical six transmem-
brane domain motif of the CDF family at their C-termini with
several (6–9) additional transmembrane domains at their N-
termini. The function of these additional transmembrane
domains is unknown but may be related to how these proteins
interact with their partners in the heteromeric complexes. Like
the ZIP proteins, many CDF family members have histidine-
rich motifs, in this case usually in the cytoplasmic loop between
transmembrane domains 4 and 5. These domains may also bind
metal during transport. Intriguingly, a splice variant of a plant
CDF protein (TgMTP1) that lacks this His-rich domain was
found to have altered substrate specificity relative to the full-
length protein [37].
Many CDF proteins have been implicated to function as
homomeric dimers or higher order complexes. These include
the Znt1, PtdMtp1, Mtp1, FieF, and Znt7 proteins [4,38–42]. As
mentioned above, two heteromeric CDF complexes have also
been identified, Msc2 in complex with Zrg17 and Znt5 bound to
Znt6 [40,43]. The mechanism of transport for many CDF
proteins appears to be via zinc/H+ or K+ antiport. The Zrc1
protein of yeast functions as a Zn/H+ antiporter while the CzcD
protein of Ralstonia may function as a H+ or a K+ antiporter
[44–46]. Therefore, despite their name, CDF proteins do not
serve as diffusion facilitators but rather as secondary active
transporters, using the gradient of other ions to drive the
transport of zinc.
3. Zinc transport across the plasma membrane in yeast
The first step in the cell biology of zinc is the transport of the
ion across the plasma membrane into the cell. Over the past few
years, many different transporters have been identified that play
this role in different organisms and cell types. Most of these are
members of the ZIP family of zinc transporters with only a few
exceptions. Among eukaryotes, the identification of plasma
membrane zinc transporters is most advanced in the yeast
Saccharomyces cerevisiae where at least four different trans-
porters are involved in zinc uptake by this single-celled
organism (Fig. 2). The primary uptake system for zinc is the
Fig. 2. An overview of zinc transport and trafficking in the yeast S. cerevisiae. ZIP family transporters are shown in blue and CDF family transporters are shown in red.
Hypothetical transporters or known proteins from other families of transporters are shown in gray. The Zap1 transcriptional activator, shown in black, is responsible for
the up-regulation of many target genes in zinc-limited cells. Zn2+ in the vacuole is likely bound by some ligand (L) to facilitate storage.
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low zinc conditions [47]. Zrt1 expression levels are up-
regulated by zinc deficiency at the transcriptional level by the
Zap1 zinc-responsive activator protein [48]. Expression of Zrt1
in zinc-limited cells is induced approximately 100-fold over
zinc-replete expression levels. Zrt1 has a remarkably high
affinity for zinc with an estimated apparent Km of 10 nM for free
Zn2+ ions. A second ZIP protein, Zrt2, has a lower affinity for
free zinc (apparent Km=∼100 nM) and plays a role in zinc
acquisition under less severe zinc-limiting conditions [34]. Zrt2
is induced by Zap1 under conditions of mild zinc limitation but
then repressed by Zap1 under more severe zinc-limiting
conditions [49]. This intriguing pattern of regulation involves
the positioning of three Zap1 binding sites within the promoter.
Two binding sites are located upstream of the TATA box and
serve to activate gene expression. A third binding site is located
downstream of TATA near the start site of transcription, and
Zap1 binding at this site blocks Zrt2 transcription.
Mutational inactivation of Zrt1 and Zrt2 revealed the
existence of additional zinc uptake systems with lower affinity.
One such system was found to be the Fet4 transporter which is
involved in the low affinity uptake of iron and copper as well as
zinc [50]. Fet4 is not a ZIP protein and, surprisingly, Fet4-
related proteins are only found in Ascomycete fungi such as S.
cerevisiae, Schizosaccharomyces pombe, Candida albicans and
Aspergillus fumigatus. A fourth system of zinc uptake in yeast is
likely to be the Pho84 high affinity phosphate transporter [51].
Pho84 is a member of the major facilitator superfamily of
transporters [52]. Mutation of the PHO84 gene confers zinc
tolerance and reduces the accumulation of zinc consistent with
Pho84 being able to transport zinc in addition to phosphate.
While likely to have a low affinity for zinc, this system is highly
induced by phosphate limitation so it may play a moresignificant role in zinc homeostasis under low phosphate
growth conditions [53].
4. Plasma membrane zinc uptake transporters in other
organisms
Many zinc uptake transporters have been identified in other
organisms over the past few years. Space limitations prevent a
full accounting of these discoveries so I will focus here on
recent advances in the field of mammalian zinc uptake
transporters with apologies to those colleagues studying other
types of organisms. There are 14 known members of the ZIP
family encoded by the human genome [30]. The Zip1/
SLC39A1 transporter is ubiquitously expressed in tissues of
mice and humans [54,55]. This protein is likely to play a role in
zinc uptake by many cell types. Zip1 has been shown to be the
major zinc uptake system in K562 erythroleukemia cells and in
prostate cells [54,56,57]. Zip1 is localized to the plasma
membrane in some cell types but not in others perhaps owing to
the zinc-responsive regulation of this protein's subcellular
localization [54,58]. In zinc-deficient cells, Zip1 migrates to the
plasma membrane while it is found associated with intracellular
compartments in zinc-replete cells [59]. In addition to Zip1, the
Zip2/SLC39A2 and Zip3/SLC39A3 proteins have also been
implicated in zinc uptake by mammalian cells [35,60,61]. More
specifically, Zip3 has been implicated in zinc uptake by
mammary epithelial cells to supply zinc to milk [62,63].
The Zip4/SLC39A4 protein has been found to be an
important transporter for the acquisition of zinc from the diet.
This role of Zip4 in dietary zinc absorption was first discovered
by two groups whose studies linked mutations in the SLC39A4
gene to a human genetic disease, acrodermatitis enteropathica
(AE) [64–66]. AE is a recessive disorder of dietary absorption.
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gene that disrupt the zinc transport function of the protein [67].
Consistent with its proposed action in dietary zinc absorption,
the Zip4 protein localizes to the apical (gut lumenal) surface of
intestinal enterocytes [60]. Moreover, expression of Zip4 in the
mouse visceral yolk sac suggests that this protein may also
deliver maternal zinc to the developing fetus [60]. It is clear that
Zip4 is not the only zinc transporter responsible for dietary zinc
uptake. Many AE mutations completely disrupt function of the
transporter [67]. Nonetheless, AE generally affects infants and
not adults indicating that other transporters play the primary role
in zinc absorption after infancy. Moreover, zinc supplements
readily suppress AE symptoms in infants suggesting the
presence of other transporters on the apical face of the
enterocytes. The Zip1 protein or another ZIP may also
participate in dietary zinc absorption.
In contrast to Zip4, the Zip5/SLC39A5 protein is expressed
on the basolateral surface of intestinal enterocytes [68,69].
Therefore, while Zip4 is responsible for zinc uptake from the
gut, Zip5 may mediate zinc transport from the bloodstream into
the enterocyte. This activity of Zip5 may serve two functions.
First, Zip5 may deliver needed zinc from body stores to the
enterocytes when dietary levels are low. Alternatively, Zip5 may
transport zinc into the enterocyte as a means to communicate the
levels of serum zinc to the enterocyte to control the level of zinc
absorption from the diet.
As a final example, a recent study has indicated the role of
yet another ZIP, Zip14/SLC39A14, in the uptake of zinc into
liver in response to acute inflammation and infection [70–72].
Under these conditions, serum zinc levels drop and liver levels
rise in a likely effort to withhold this essential metal nutrient
from the invading pathogen. Zip14 expression in the liver is
induced in response to interleukin-6 (IL-6) during the acute
phase response. These results suggested that induction of Zip14
by IL-6 is responsible for the serum hypozincemia associated
with infection.
5. Plasma membrane zinc efflux transporters
Plasma membrane efflux transporters are important compo-
nents of cellular and organismal zinc homeostasis in many
organisms. These transporters mediate the efflux of intracellular
zinc to prevent the cellular overaccumulation of the metal ion
thereby saving the cell from the toxic consequences of zinc
overload. In addition, zinc efflux systems are critical for the
movement of zinc across polarized epithelial cell layers. For
example, during zinc absorption in the intestine, resorption of
zinc in the kidney, and during embryonic development, delivery
of zinc to the bloodstream or the embryo is dependent on the
uptake of zinc at one face of polarized epithelial cells and the
subsequent efflux of the metal on the other side of those cells.
Zinc efflux is a critical component of zinc homeostasis in E.
coli and many other bacteria [26]. Among eukaryotes, yeast
may be unusual in not having any zinc efflux systems. These
cells transport excess zinc into an intracellular organelle for zinc
storage and detoxification rather than release that zinc from the
cell (see below). In mammalian cells, the CDF family memberZnt1/SLC30A1 has been implicated in effluxing zinc for both
cellular zinc homeostasis and trans-epithelial zinc trafficking
[4,73–75]. The role of zinc efflux transporters in cellular zinc
homeostasis may be particularly important in the brain where
high levels of zinc are accumulated by neurons following
ischemia or epileptic seizures [73,76]. In plants, the TgMtp1
CDF protein of Thlaspi goesingense and the Arabidopsis Hma2
and Hma4 transporters of the P-type ATPase family have been
implicated in the plasma membrane efflux of zinc from the
vascular tissues of roots, stems, and leaves [77–79].
6. The transport of zinc into and out of intracellular
organelles
6.1. The secretory pathway
Many zinc metalloproteins are secreted or are resident within
the secretory pathway. Notable examples of secreted proteins
that require zinc are the matrix metalloproteases (MMPs). The
proteolytic activity of these secreted proteins are required for
developmental processes such as organ branching, morphogen-
esis, angiogenesis, and extracellular matrix remodeling [80].
MMPs also play important roles in cancer progression and
metastasis by allowing cell migration into tissues and by
promoting angiogenesis and the vascularization of tumors.
Secreted alkaline phosphatases are also zinc dependent [72]. In
addition, the lumen of the ER is the site for the initial folding
and post-translational modification of proteins destined for
secretion or residency within secretory pathway, and many of
these processes are zinc-dependent. For example, glycosylpho-
sphatidylinositol phosphoethanolamine transferases (GPI-
PETs) in the endoplasmic reticulum act in the biosynthesis of
GPI anchors that attach many proteins to cell surfaces. GPI-
PETs have a zinc-binding motif similar to that found in alkaline
phosphatases [81] and, in both mammals and yeast, require zinc
for their function [82,83]. The yeast DnaJ homolog Scj1 is a
protein co-chaperone in the ER that contains two zinc fingers
and requires zinc for its function [84]. Disrupting Scj1 function
causes defects in protein folding and less effective degradation
of aberrant proteins by ER quality control mechanisms [85].
Similarly, the ER chaperones calnexin and calreticulin require
zinc for their interaction with the ERp57 thiol oxidoreductase
[86]. These chaperones are needed for glycosylation of secreted
and lumenal glycoproteins.
The Golgi also contains zinc-dependent resident proteins.
For example, cleavage of the Alzheimer's disease Aβ protein
from the amyloid precursor protein in the Golgi depends on
resident zinc metalloproteases in that compartment [87]. The
packaging of insulin in secretory granules relies on zinc. Insulin
is packaged in a crystalline structure within these vesicles with a
2:1 Zn:insulin stoichiometry [88] (see below). The hexameriza-
tion of proinsulin that occurs in the Golgi, an early step in
forming the Zn:insulin crystal, is zinc-dependent as well [89].
There is very little information regarding where in the
secretory pathway zinc is delivered to specific resident and
secreted apoproteins. The zinc requirement of lumenal ER
proteins such as DnaJ-like chaperones and GPI-PETs indicates
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processing indicates that some zinc is delivered to the cis
compartment of the Golgi apparatus [89]. Matrix metallopro-
teases, which are inhibited by an intramolecular repression
domain, can be activated in the Golgi by proteolytic removal of
this inhibitory region [90,91]. Because MMP activity depends
on zinc, these observations indirectly demonstrate that zinc is
bound to these proteins by the time they reach the Golgi. Thus,
these few examples indicate that zinc is delivered to the ER and
Golgi compartments by zinc transporter proteins.
Zinc transporters responsible for delivery of zinc to the
secretory pathway have been recently identified, and these
proteins belong to the CDF family. For example, in yeast, the
heteromeric Msc2/Zrg17 complex mediates zinc transport into
the ER [43,92,93] (Fig. 2). Mutational inactivation of either or
both subunits of this complex results in pleiotropic defects in
ER function, including induction of the Unfolded Protein
Response (UPR) and defects in ER-associated protein degra-
dation. Cell wall biogenesis, a process highly dependent on
secretory pathway function, is also likely to be disrupted in
msc2 or zrg17 mutants.
The Msc2/Zrg17 transporter complex is important for
transport of zinc into the ER under low zinc conditions. When
higher zinc levels are provided in the medium, their mutant
phenotypes are completely suppressed. This indicates that other
transport mechanisms are present to supply zinc to the ER. The
vacuolar CDF transporters Zrc1 and Cot1 (see below) were
shown to contribute to ER zinc [92]. These proteins may be
active in the early secretory pathway soon after their synthesis
and before they transit to the vacuole. Surprisingly, in a mutant
disrupted for Msc2, Zrg17, Zrc1 and Cot1, increased exogenous
zinc could still suppress the defects in ER function. Thus,
additional pathways of ER zinc transport exist in yeast.
Supply of zinc to the Golgi may occur by vesicular
trafficking of ER zinc to that compartment. Alternatively, zinc
transporters may be active in the Golgi as well. In yeast, not all
of the Msc2/Zrg17 complex localizes to the ER suggesting that
some fraction may be present in the Golgi. In vertebrate cells,
the Znt5/Znt6 complex localizes to the Golgi and is required for
supplying zinc to alkaline phosphatase and probably to other
secreted zinc proteins [94–96]. In contrast, the Znt7/SLC30A7
protein, which also localizes to the Golgi, forms homo-
oligomers and also transports zinc into the Golgi [40,97]. To
date, no CDF transporters have been localized specifically to the
ER in vertebrates. This is in striking contrast to yeast where
Msc2 and Zrg17 are predominantly localized to the ER. Supply
of zinc to the ER in vertebrate cells may involve the transport
activity of the Golgi-localized transporters as they transit
through the ER as proposed above for the yeast vacuolar zinc
transporters. Alternatively, retrograde vesicular trafficking from
the Golgi to the ER may carry labile zinc back to the ER for the
function of metalloproteins in that compartment. A similar
retrograde trafficking of ions has been proposed for Ca2+ [98].
Zinc may also be exported from the Golgi. The mammalian
Zip7/SLC39A7 protein localizes to the Golgi and appears to
mediate transport of secretory pathway zinc back to the
cytoplasm [99]. This may be a means to recover unused zincin the secretory pathway prior to its loss by secretion. It is not
clear if S. cerevisiae uses a similar strategy but a yeast ZIP
transporter related to Zip7, called Yke4, could fulfill this
function.
Finally, secretory vesicles of various types have also been
shown to contain zinc transporters in their membranes. For
example, the Znt4/SLC30A4 protein is required for the transfer
of zinc to milk; mutational defects in Znt4 cause the lethal milk
phenotype in mice [100]. This transporter is localized to
vesicles in cells that are presumably involved in the secretion of
zinc [101,102]. Similarly, the Znt3/SLC30A3 transporter is
localized to synaptic vesicles in certain types of neurons that
release high levels of zinc along with neurotransmitters such as
glutamate [103,104]. Intriguingly, the pool of synaptic zinc may
be a critical factor in the development of Alzheimer's disease as
indicated using a mouse model of this disease [105]. Finally, the
Znt8/SLC30A8 transporter is associated with the secretory
granules of pancreatic β-cells [106,107]. Znt8 is likely to supply
the zinc required for the packaging of insulin in these granules
as described above.
6.2. The fungal and plant vacuole
The vacuole of yeast and plants serves as a major site of zinc
sequestration and detoxification [108–110] (Fig. 3). For
example, in S. cerevisiae, wild type cells can tolerate exogenous
zinc concentrations as high as 5 mM. When the transport
systems for vacuolar zinc sequestration are disrupted (see
below), the maximum level of zinc tolerable by the cells drops
by ∼100-fold [3,111–113].
Chronic exposure to zinc at the millimolar levels that can be
tolerated by wild type cells is not often encountered by yeast
growing in their normal environment. Thus, vacuolar seques-
tration is likely to be more important to the cell for growth under
other conditions. One such condition is “zinc shock.” Zinc
shock occurs when cells are grown under zinc-limiting
conditions and then resupplied with even low levels of zinc.
Zinc-deficient cells are poised to accumulate substantial
amounts of zinc due to the up-regulation of the plasma
membrane transporter Zrt1. When resupplied with zinc, these
cells accumulate large amounts of the metal ion before
transcriptional and post-translational mechanisms that regulate
Zrt1 can shut off additional uptake. We have shown that mutant
cells unable to sequester zinc in the vacuole during zinc shock
are sensitive to zinc concentrations as low as 0.1 μM [114].
Given that microbial cells growing in the environment live an
existence of sporadic nutrient availability, we believe the
primary function of the vacuole in zinc detoxification is during
zinc shock caused by fluctuations in zinc availability.
Zinc sequestered within the vacuole also serves as a storage
pool of zinc that can be mobilized under zinc-deficient
conditions for use by the cell. Our recent results indicate that
zinc can accumulate in the vacuole to millimolar levels (C.
Simm, A. LeFurgey, P. Ingram, and D. Eide, unpublished
observation). This is a sufficient level of zinc to support many
yeast cell generations in the absence of an exogenous supply.
Zinc uptake into the yeast vacuole is mediated by two members
Fig. 3. Accumulation of zinc in the yeast vacuole. The zinc-responsive fluorophore FuraZin-1 acetoxymethyl ester was loaded into the vacuole of zinc-limited wild
type cells. These cells were then treated with zinc and fluorophore signal was detected by epifluorescence (Epi). Nomarski optics (Nom) shows the large yeast vacuole
present in many cells and the overlay of the images shows the localization of the fluorophore to the vacuole. FuraZin-1 is a useful probe for the qualitative detection of
vacuolar zinc in yeast [114].
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to be a Zn2+/H+ antiporter which allows zinc accumulation in
the vacuole to be driven by the proton concentration gradient
provided by the vacuolar H+-ATPase [44]. The Cot1 protein
may act in a similar fashion, although its biochemical properties
have not yet been analyzed. Zinc release to the cytosol under
conditions of zinc deficiency is mediated by Zrt3, a member of
the ZIP family of transporters [3]. Zrt3 expression is up-
regulated under low zinc conditions to facilitate this mobiliza-
tion of vacuolar zinc.
In contrast to S. cerevisiae, the ER may be a major site of zinc
detoxification and storage in the fission yeast, Schizosacchar-
omyces pombe. The S. pombe Zhf protein of the CDF family
localizes to the ER and mutations in its gene results in reduced
cellular zinc accumulation and zinc sensitivity [115]. These
effects are similar to what is seen for zrc1 and cot1mutants of S.
cerevisiae and are not observed for msc2 or zrg17 mutants.
In plants, members of the CDF family of transporters have
been implicated in the vacuolar accumulation of zinc. For
example, the ArabidopsisMtp1 protein has been localized to the
vacuolar membranes of shoots and leaf cells and can transport
zinc when expressed in Xenopus laevis oocytes. Reduced
expression of Mtp1 results in zinc sensitivity and lower zinc
accumulation in plant tissues [116–118]. Plant proteins
responsible for mobilizing vacuolar zinc have not yet been
identified. However, there are several members of the ZIP
family encoded by plant genomes. For example, Arabidopsis
has 11 ZIP genes, and one or more of these may be playing roles
analogous to yeast Zrt3 [29].
Zinc stored within vacuoles may not simply accumulate as
free Zn2+ ions. X-ray absorption spectroscopy analysis of
vacuolar zinc in plants indicates that Zn2+ may instead
accumulate bound to organic anions. For example, in
Arabidopsis halleri, a plant species capable of hyperaccumulat-
ing large amounts of zinc, the metal was found complexed
primarily with phosphate and/or organic acids such as malate
and citrate depending on the growth conditions and the plant
tissues examined [119]. Similar results were obtained with
Thlaspi caerulescens, another zinc hyperaccumulating plant
species [120]. Binding of vacuolar zinc by such compoundsmay provide a means of accumulating large amounts of zinc
within the vacuolar compartment for storage and detoxification.
Similarly, the glutamate levels in synaptic vesicles are
proportional to their zinc accumulation, suggesting that the
anion influences the zinc loading capacity of the vesicle [121].
It is unclear at this time if vacuolar zinc in yeast is similarly
bound to anions within the vacuole, but it seems a likely
possibility.
6.3. Zincosomes
Vesicular storage sites for zinc may also exist in mammalian
cells. Several studies have used zinc-responsive fluorophores
(e.g., TSQ, zinquin, Zinpyr-1) to examine the distribution of
labile intracellular zinc [93,102,122–127]. These studies have
consistently indicated that labile zinc can be detected within
membrane-bound vesicles in a large variety of mammalian cell
types. These vesicles have been designated “zincosomes”
[128,129], a term I will use here for convenience. However,
the relationship of zincosomes to established organelles is not
clear. Palmiter and colleagues showed that, at least in one cell
type, these zinc-containing vesicles are late endosomes
[122,130]. Whether zincosomes correspond to late endosomes
in other cells remains to be tested.
Zincosomes have also been observed in yeast [93,131]. As
shown in Fig. 4, zincosomes accumulate in zinc-treated yeast
cells. This accumulation is dependent on the Zrt1 zinc uptake
transporter but not on the Zrc1 or Cot1 vacuolar zinc
transporters nor is it dependent on endocytosis [131]. Co-
localization studies indicate that yeast zincosomes do not
correspond to the vacuole, Golgi or the prevacuolar compart-
ment (C. MacDiarmid and D. E., unpublished results). Thus,
the identity and function of these compartments are still
unknown.
What is the function of zincosomes in zinc metabolism and
homeostasis? Some studies suggested a role in detoxifying
excess zinc [122]. For example, treating baby hamster kidney
cells with high zinc greatly increased the number and
fluorescence intensity of the vesicles, indicating an increase in
vesicular zinc levels. Moreover, the zinquin-staining vesicles
Fig. 4. Detection of yeast zincosomes. The zinc-responsive fluorophore zinquin
was loaded into zinc-limited wild type or mutant yeast cells. These cells were
then treated with zinc (100 μM for 10 min) and the zinc-responsive fluorophore
signal was detected by epifluorescence (Epi). Nomarski optics (Nom) shows the
large yeast vacuole present in many cells. Zinquin staining does not co-localize
with the vacuole. Untreated wild type cells (designated WT -zinc) are shown for
comparison. Zinquin was kindly provided by T. O'Halloran.
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transporter, whose expression is known to confer zinc tolerance.
It has also been noted that stress agents, such as nitric oxide
(NO), increase labile zinc levels probably due to the release of
zinc from proteins [16,127–129,132]. This newly released
labile zinc subsequently accumulated in zincosomes. Thus, the
zincosome may serve to buffer cytosolic zinc from transient
perturbations of zinc homeostasis much like the vacuole in
yeast. Other studies have implicated zincosomes in the storage
of zinc that can be later mobilized under zinc deficiency. For
example, the total zinc content of cells, and the fluorescence
intensity of the zinquin-staining vesicles all decreased when
HL60 cells [133] or rat hepatocytes [16] were transferred from
zinc-replete to low zinc culture media. These results suggest that
zinc has been stored in the vesicles and is mobilized for use
during this transition.
6.4. Mitochondria
Zinc is required in the matrix of the mitochondria for
function of proteins within that compartment. In yeast, these
include alcohol dehydrogenase 3 (Adh3) which converts
acetaldehyde to ethanol as a means to shuttle NADH across
the inner membrane [134]. The Leu4 protein, alpha-
isopropylmalate synthase, mediates the first step of leucine
synthesis. Leu4 is found in the matrix and is a zinc
metalloenzyme [135]. Zim17 is a zinc finger matrix protein
required for protein import [136]. Finally, labile zinc can bedetected in the mitochondria of mammalian neuronal cells
using a zinc-responsive fluorophore, RhodZin-3 [137].
Further studies by these authors indicate that mitochondrial
zinc in neurons is held in that compartment by the
mitochondrial membrane potential [138]. Disruption of that
membrane potential results in the release of zinc to the
cytosol. This release of mitochondrial labile zinc may be a
contributing cause of neuronal cell death during ischemia or
epilepsy [139].
These examples indicate that mechanisms must exist to get
zinc into the mitochondria. Zinc must first traverse the outer
membrane, most likely through the porin channels. Then, the
zinc must cross the inner membrane via transporter proteins.
Previous studies suggested that zinc may enter the mitochon-
dria matrix via the Ca2+ uniporter system. For example,
rhuthenium red, a Ca2+ uniporter blocker, protects mitochon-
dria from the adverse effects of high zinc [140–142]. However,
these studies did not provide direct evidence for mitochondrial
Zn2+ uptake.
A recent study of rat brain mitochondria by Reynolds and
colleagues using methods to directly visualize mitochondrial
zinc accumulation indicated both Ca2+ uniporter-dependent and
uniporter-independent pathways [143]. Zinc uptake was
partially dependent on the mitochondrial membrane potential,
and the transporter activities were found to be of high affinity
with apparent Km's of ∼1 μM. This value is likely be an
overestimate of their true apparent Km's because the binding of
substrate by organic anions in the uptake assay buffer
(glutamate, malate) was not considered. Thus, the affinity of
these transporters is likely to be even higher and therefore in a
physiologically relevant range. These studies also detected zinc
efflux from mitochondria.
What is the substrate for mitochondrial zinc influx
transporters? Is the substrate free Zn2+, or can zinc-chelate
complexes serve as substrates? An intriguing study addressing
this question was recently published by Costello and colleagues
[144]. In vitro studies of zinc uptake into mitochondria isolated
from rat prostate cells revealed the activity of a mitochondrial
zinc transporter with an apparent Km of approximately 60 μM
when assayed using 65Zn supplied as ZnCl2. Such a high Km
argues that this system is unlikely to be physiologically
relevant. Surprisingly, however, it was found that several
zinc-chelates including zinc-citrate, zinc-aspartate, and zinc-
histidine also had similar apparent Km's for transport as was
observed with ZnCl2. These compounds can bind zinc
relatively tightly and thereby reduce the free Zn2+ available
for transport. The fact that these chelators did not inhibit zinc
uptake despite their ability to reduce free zinc suggests that
transport may occur via ligand exchange reactions between
zinc–chelate complexes and the transporter. This hypothesis
was supported by the observation that the zinc traverses the
membrane while the chelator does not [144]. Alternatively, it
has been proposed that metallothionein may serve as one source
of zinc for uptake to the mitochondrial matrix. MT can be
detected in the intermembrane space of mitochondria [145], and
MT-supplied zinc can be taken up into isolated mitochondria in
vitro [146].
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In this review, I have attempted to provide an overview of
our current knowledge of the cell biology of zinc. What may be
most obvious from this discussion is all that we do not yet know.
Clearly, several questions of great importance still need to be
addressed. First, what are the intracellular forms of labile zinc,
and how is that zinc delivered to zinc metalloproteins? Do any
zinc metalloproteins obtain their zinc from metallochaperones?
In addition, what are the biochemical mechanisms used by ZIP
and CDF proteins to mediate zinc transport across cellular
membranes? While we have some indication of how CDF
proteins work, we still have no idea for the ZIPs. What are the
various functions of the many members of these families that
are found in organisms? For example, the human genome
encodes 14 ZIPs and 9 CDFs. What do all of these proteins do?
Even in the relatively simple yeast, we still do not know the
function of all the ZIP and CDF proteins. In addition, we are still
learning of new roles for previously characterized transporter
proteins. How does zinc get into and out of mitochondria and
other organelles? We have an evolving picture, but it is still very
incomplete. What are “zincosomes” and how do they participate
in zinc homeostasis and trafficking? Finally, although it was
beyond the scope of this review, we need to consider how the
various transport and trafficking systems are regulated by zinc
availability, metabolic demands for zinc, and other factors to
maintain zinc homeostasis and optimal cell function. Thus,
while we have learned much over the past few years, it is
exciting to consider the new horizons that still await researchers
in this field.
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